Information Labeling in Instructions of Anti-tumor Drugs for Intravenous Infusion in a Hospital

doi:10.19803/j.1672-8629.2021.10.18

Abstract

Abstract: Objective To investigate the problems with information labeling in instructions of antineoplastic drugs for intravenous infusion in order to provide reference for the rational use of antineoplastic drugs. Methods The instructions of anti-tumor drugs for intravenous infusion were collected from a hospital, the completeness of information in the instructions was statistically analyzed, and problems with the instructions of anti-tumor drugs for intravenous infusion were investigated. Results Among the ninety-one instructions of antineoplastic drugs for intravenous infusion, there were eight (7.41%) that involved pre-treatment. There were five instructions (5.49%) involving infusion instruments, two (2.20%) involving flushing tubes, eight involving (8.79%) infusion stability, fifteen (16.48%) involving the need for monitoring during infusion and thirteen involving (14.29%) rescue measures. Conclusion The information labeled in the 91 instructions of anti-tumor drugs for intravenous infusion is seriously inadequate. Therefore, it is necessary to revise the instructions, and standardize information labeling in drug instructions.

Key words: drug instruction, labeling information, antineoplastic drug, intravenous infusion

CLC Number:

R979.1

ZHAO Shuang, GU Rui, SONG Yanqing, WANG Xiangfeng, MIAO Qiuli. Information Labeling in Instructions of Anti-tumor Drugs for Intravenous Infusion in a Hospital[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 978-980.

References

[1] Yuan CM.Analysis and research on adverse reactions of antineoplastic drugs[J]. Chinese Prescription Drugs(中国处方药), 2019, 17(9): 23-24.
[2] Yang F, Wang D.Analysis and prevention of adverse reactions of antineoplastic drugs[J]. Capital Food and Medicine(首都食品与医药), 2019, 26(19): 79.
[3] Wang YQ, Li YZ, Zhen JC.Basic skills and practice of hospital pharmacists(医院药师基本技能与实践)[M]. Beijing: People’s Health Publishing House, 2013.
[4] State Food and Drug Administration. Regulations on the administration of drug instructions and labels[EB/OL]. (2006-03-16) [2019-12-20].. Regulations on the administration of drug instructions and labels[EB/OL]. (2006-03-16) [2019-12-20]. http://www.gov.cn/ziliao/flfg/2006-03/16/content_228465.htm.
[5] State Food and Drug Administration. Notice on printing and distributing detailed rules for specification of chemical and biological products[EB/OL]. (2006-05-10) [2019-12-20]. http://www.nmpa.gov.cn/WS04/CL2196/323547.html.
[6] Matthew P.Management of digoxin toxicity[J]. Australian Prescriber, 2016, 39(1): 18-20.
[7] Jing YY.Analysis of 105 cases of new serious adverse drug reactions caused by intravenous drip[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2010, 7(4): 240-242.
[8] Wu YP, Jiao YH.Guidelines for Clinical Intravenous Drug Use(临床静脉用药调配和使用指南) [M]. Beijing: People’s Health Publishing House, 2010.
[9] Zhang X, Niu J, Wu XY.Pareto diagram analysis of irrational drug use prescriptions in pharmacy intravenous admixture service[J]. Chinese Journal of Pharmacovigilance, 2017, 14(3): 183-185.
[10] Wang YL.Investigation and analysis of 40 groups of injection drug instructions in our hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018,15(3): 147-168.
[11] Cheng J, Gong XY, Li CH.Investigation and analysis of intravenous infusion of antineoplastic drugs in a hospital[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2016, 36(24): 2213-2217.
[12] Wang XJ, Fan XC, Li DN.Intervention and analysis of irrational use of cytotoxic drugs[J]. Journal of Guangdong Pharmaceutical University(广东药科大学学报), 2018, 34(6): 112-115, 119.
[13] Yang YQ, Pei BX, Liang X, et al.Analysis of irrational medical orders in the venous allocation center of tumor pharmacy in our hospital[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2012, 9(3): 160-162.
[14] Li W, Tang F.Analysis and discussion on the method of anti-tumor drug order audit[J]. Modern Medicine and Health(现代医药卫生), 2015, 31(2): 310-312.
[15] Wang HY, Zhang HF.Analysis of irrational use of antineoplastic drugs in inpatients of our hospital in the first half of 2015[J]. Drug Evaluation(药品评价), 2016, 13(4): 44-47.